FGF17: Potential Drug Target for Cancer and Other Diseases (G8822)

Target Name: FGF17

NCBI ID: G8822

FGF17

FGF17: Potential Drug Target for Cancer and Other Diseases

FGF17 (Fibroblast Growth Factor 17), also known as HH20, is a protein that plays a crucial role in the development and maintenance of tissues, including skin, hair, and nails. It is a member of the FGF family, which is known for their ability to stimulate cell proliferation and growth. FGF17 is a potent regulator of cell proliferation, and has been shown to play a key role in the development of a variety of diseases, including cancer.

One of the key functions of FGF17 is its ability to promote the growth and differentiation of stem cells. Stem cells are a type of cell that have the ability to develop into any type of cell in the body, and they play a vital role in the development and maintenance of tissues. FGF17 helps to regulate the stem cell proliferation and differentiation by controlling the activity of several key genes.

FGF17 has also been shown to play a key role in the development of cancer. Many studies have shown that FGF17 levels are elevated in various types of cancer, and that it plays a role in the development of these diseases. For example, some studies have shown that high levels of FGF17 are associated with the development of skin cancer, and that inhibiting FGF17 activity may be a useful treatment for this type of cancer.

In addition to its role in cancer development, FGF17 has also been shown to be involved in a variety of other processes in the body. For example, it has been shown to play a key role in the development and maintenance of tissues, including the skin and hair. FGF17 helps to regulate cell growth and differentiation, and is essential for the formation of these tissues.

FGF17 is also involved in several other processes in the body, including the immune system. FGF17 has been shown to play a key role in the development and regulation of immune cells, including T cells and natural killer cells. It is also involved in the regulation of inflammation, and has been shown to play a vital role in the immune response to infection.

Despite its many functions, FGF17 is still an relatively well-unknown protein. There is ongoing research into its role in various diseases, and it is likely that many more studies will be conducted in the future to better understand its properties and its potential as a drug target.

In conclusion, FGF17 is a protein that plays a vital role in the development and maintenance of tissues in the body. It is a potent regulator of cell proliferation and has been shown to play a key role in the development of a variety of diseases, including cancer. Further research is needed to better understand its properties and its potential as a drug target.

Protein Name: Fibroblast Growth Factor 17

Functions: Plays an important role in the regulation of embryonic development and as signaling molecule in the induction and patterning of the embryonic brain. Required for normal brain development

The "FGF17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FGF17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets